Compassionate Access is a 501(c)(3) non-profit organization; our mission is to make new, potentially curative treatments available to patients who have no other options, by creating an ethical, fast track connection to therapeutics not yet approved by the FDA. Our initial focus is on cancer.
Scientific advances are slowing making their way to market, but patients can’t wait. Many of the most needy patients can’t afford new life-saving treatments and also aren’t eligible for formal clinical trials. In addition, companies developing new therapies are hamstrung by regulations and complex procedures. We need to break down these unnecessary barriers, provide more direct access to cutting edge therapies for patients in need, accelerate the drug discovery process, and enable companies to get their new therapeutics into the hands of patients faster. Our mission is to be a catalyst for such changes in the therapeutic approval process.
WE’RE HERE FOR: